NewsAnother patent approval in the US related to Episurf Medical’s 3D-based damage assessment tool

Episurf Medical has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent being approved is within the area of 3D-based assessment of joint lesions, and complements Episurf Medical’s first US patent approval within that field, received in 2017.

“This patent covers important parts of our technology in the exciting field of medical imaging, where we are continuously working with protection of our intellectual properties” comments Pål Ryfors, CEO, Episurf Medical.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69